Insider · CIK 0001821352

Began Marc A

Reports to the SEC for 2 companies · ALACHUA, FL

sec.gov

Transactions

Companies

Filings

CIK

0001821352

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	AXGNAxogen, Inc.M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+67.5K sh	$8.16	+$551K	117,635
2026-08-10	AXGNAxogen, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	−67.5K sh	—	—	22,500
2026-08-10	AXGNAxogen, Inc.S Sale	EVP & General Counsel	SSale	−67.5K sh	$47.34	−$3.2M	50,135
2026-03-01	AXGNAxogen, Inc.M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+11.3K sh	—	—	54,562
2026-03-01	AXGNAxogen, Inc.F Tax Payment	EVP & General Counsel	FTax Payment	−4,427 sh	$30.65	−$136K	50,135
2026-03-01	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+11.3K sh	—	—	11,250
2026-02-26	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	EVP & General Counsel	AAward	+23K sh	—	—	23,000
2026-02-26	AXGNAxogen, Inc.F Tax Payment	EVP & General Counsel	FTax Payment	−8,753 sh	$31.90	−$279K	43,312
2026-02-26	AXGNAxogen, Inc.A Award	EVP & General Counsel	AAward	+33.8K sh	—	—	52,065
2025-12-11	AXGNAxogen, Inc.S Sale	EVP & General Counsel	SSale	−13.2K sh	$30.00	−$397K	18,285
2025-12-09	AXGNAxogen, Inc.S Sale	EVP & General Counsel	SSale	−9,278 sh	$31.21	−$290K	31,507
2025-12-04	AXGNAxogen, Inc.A Award	EVP & General Counsel	AAward	+22.5K sh	—	—	40,785
2025-03-25	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	EVP & General Counsel	AAward	+55K sh	—	—	55,000
2025-03-04	AXGNAxogen, Inc.F Tax Payment	EVP & General Counsel	FTax Payment	−5,901 sh	$18.36	−$108K	18,285
2025-03-01	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	−22.5K sh	—	—	22,500
2025-03-01	AXGNAxogen, Inc.M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+22.5K sh	—	—	24,186
2025-02-25	AXGNAxogen, Inc.F Tax Payment	EVP & General Counsel	FTax Payment	−814 sh	$16.50	−$13.4K	1,686
2025-02-22	AXGNAxogen, Inc.A Award	EVP & General Counsel	AAward	+2,500 sh	—	—	2,500
2024-02-22	AXGNAxogen, Inc. · Performance Stock UnitsA Award	EVP & General Counsel	AAward	+68.6K sh	—	—	68,600
2022-12-22	ABIOMED INCPerf ormance Stock UnitsA Award	VP & GENERAL COUNSEL	AAward	+24K sh	—	—	24,029
2022-12-22	ABIOMED INCD Disposition to Issuer	VP & GENERAL COUNSEL	DDisposition to Issuer	−12.2K sh	—	—	0
2022-12-22	ABIOMED INCStock Option (Right to Buy)D Disposition to Issuer	VP & GENERAL COUNSEL	DDisposition to Issuer	−5,125 sh	—	—	0
2022-12-22	ABIOMED INCStock Option (Right to Buy)D Disposition to Issuer	VP & GENERAL COUNSEL	DDisposition to Issuer	−2,961 sh	—	—	0
2022-12-22	ABIOMED INCStock Option (Right to Buy)D Disposition to Issuer	VP & GENERAL COUNSEL	DDisposition to Issuer	−7,000 sh	—	—	0
2022-12-22	ABIOMED INCPerf ormance Stock UnitsD Disposition to Issuer	VP & GENERAL COUNSEL	DDisposition to Issuer	−24K sh	—	—	0
2022-11-05	ABIOMED INCF Tax Payment	VP & GENERAL COUNSEL	FTax Payment	−1,548 sh	$373.99	−$579K	12,237
2022-11-04	ABIOMED INCS Sale	VP & GENERAL COUNSEL	SSale	−2,000 sh	$373.71	−$747K	13,785
2022-08-29	ABIOMED INCS Sale	VP & GENERAL COUNSEL	SSale	−500 sh	$255.95	−$128K	15,785
2022-05-29	ABIOMED INCA Award	VP & GENERAL COUNSEL	AAward	+2,200 sh	—	—	17,741
2022-05-29	ABIOMED INCF Tax Payment	VP & GENERAL COUNSEL	FTax Payment	−976 sh	$266.34	−$260K	16,765
2022-05-29	ABIOMED INCF Tax Payment	VP & GENERAL COUNSEL	FTax Payment	−480 sh	$266.34	−$128K	16,285
2022-05-26	ABIOMED INCA Award	VP & GENERAL COUNSEL	AAward	+4,680 sh	—	—	15,541
2022-05-25	ABIOMED INCF Tax Payment	VP & GENERAL COUNSEL	FTax Payment	−298 sh	$249.19	−$74.3K	10,861
2021-11-06	ABIOMED INCF Tax Payment	VP & GENERAL COUNSEL	FTax Payment	−152 sh	$361.71	−$55K	11,159
2021-11-03	ABIOMED INCA Award	VP & GENERAL COUNSEL	AAward	+6,975 sh	—	—	12,860
2021-11-03	ABIOMED INCF Tax Payment	VP & GENERAL COUNSEL	FTax Payment	−1,549 sh	$349.76	−$542K	11,311
2021-07-23	ABIOMED INCF Tax Payment	VP & GENERAL COUNSEL	FTax Payment	−106 sh	$323.54	−$34.3K	5,885
2021-05-29	ABIOMED INCF Tax Payment	VP & GENERAL COUNSEL	FTax Payment	−480 sh	$284.58	−$137K	5,991
2021-05-25	ABIOMED INCStock Option (Right to Buy)A Award	VP & GENERAL COUNSEL	AAward	+2,961 sh	—	—	2,961
2021-05-25	ABIOMED INCA Award	VP & GENERAL COUNSEL	AAward	+2,000 sh	—	—	6,471
2020-11-06	ABIOMED INCF Tax Payment	VP & GENERAL COUNSEL	FTax Payment	−153 sh	$272.40	−$41.7K	4,471

Recent filings

Accepted (ET)
Aug 124
Began Marc A0000805928-26-000099
SEC(opens sec.gov)
Mar 24
Began Marc A0000805928-26-000042
SEC(opens sec.gov)
Dec 124
Began Marc A0000805928-25-000170
SEC(opens sec.gov)
Dec 104
Began Marc A0000805928-25-000162
SEC(opens sec.gov)
Dec 54
Began Marc A0000805928-25-000151
SEC(opens sec.gov)
Mar 264
Began Marc A0000805928-25-000044
SEC(opens sec.gov)
Mar 54
Began Marc A0000805928-25-000035
SEC(opens sec.gov)
Feb 264
Began Marc A0000805928-25-000019
SEC(opens sec.gov)
Feb 234
Began Marc A0001209191-24-003887
SEC(opens sec.gov)
Dec 274
Began Marc A0001415889-22-013011
SEC(opens sec.gov)

Companies

Address

13631 PROGRESS BLVD., SUITE 400

ALACHUA, FL, 32615